IGF1R and invasive ductal breast carcinoma: In one case of ductal adenocarcinoma that had received neoadjuvant treatment, the levels of IGF1R/PCNA signals went from moderate to none with an apparent decrease in nuclear IGF1R as determined by IHC (Fig 2).